\(
\def\WIPO{World Intellectual Property Organisation}
\)
Sources of Biopharmaceutical Innovation : An Assessment of Intellectual Property.
2015
Форматы
| Формат | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DataCite | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Cite
Citation
Files
Полное описание
Название
Sources of Biopharmaceutical Innovation : An Assessment of Intellectual Property.
Вариант заголовка
Economic Research Working Paper No. 24
Автор
Тип объекта
Working paper
Описание
14 pages ; [28] cm.
ISSN
2957-8256
Резюме
An analysis of new, FDA-approved molecular entities reveals dynamism in terms of new innovation. An assessment of the first patent for each drug reveals that the pharmaceutical industry, particularly large, established companies in North America, tend to dominate the field. Whereas inventors continue to found biotechnology companies at a steady rate, recent trends suggest these inventors more often come from the private sector.
Серия
Формат файла
Digital publication.
Серии
Economics Working Papers.
Переводы
Опубликовано
Geneva, Switzerland : [World Intellectual Property Organization], 2015.
Язык(и)
eng
Запись имеется в